BSMC

Brandes U.S. Small-Mid Cap Value ETF

Small / Mid CapBATSBrandes ETF
$40.94
$0.05 (+0.12%)
Delayed ≥20 min · Aug 13, 2026

Key Statistics

Net Assets (AUM)
$177.68M
Expense Ratio
See prospectus
Previous Close
$40.89
Day Range
- – -
52-Week Range
$32.31 – $41.46
Volume
7.06K
Avg Vol (50D)
-
Beta
0.67

Historical Performance

1M
+3.58%
3M
+11.75%
6M
+7.07%
YTD
+18.44%
1Y
+26.99%
3Y
5Y

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

IMKTA Ingles Markets, Incorporated 3.08%
JP Morgan Trust Ii 2.97%
ELAN Elanco Animal Health Inc 2.79%
INVX Innovex International Inc. 2.78%
IFF International Flavors & Fragrances Inc. 2.66%
XRAY Dentsply Sirona Inc 2.44%
SCHL SCHOLASTIC CORP 2.43%
UNF Unifirst Corp 2.43%
DOX AMDOCS LTD 2.35%
KMT Kennametal Inc 2.30%
IPGP IPG Photonics Corp 2.24%
NPK NATIONAL PRESTO INDUSTRIES INC 2.23%
EPC Edgewell Personal Care Co 2.18%
HAL Halliburton Company 2.14%
MD Pediatrix Medical Group Inc 2.13%
ZBH Zimmer Biomet Holdings Inc 2.12%
HCSG Healthcare Services Group Inc. 2.08%
CFG Citizens Financial Group Inc 2.00%
OMC Omnicom Group Inc 1.97%
TXT Textron Inc. 1.96%
NTGR Netgear Inc 1.92%
BBY Balfour Beatty PLC 1.66%
TAP Molson Coors Beverage Company 1.65%
TFX Teleflex Incorporated 1.65%
EPAM EPAM Systems Inc. 1.61%

Top 25 holdings as of Mar 31, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About BSMC

TheFund is an actively managed exchange-traded fund (“ETF”) that seeks to attain its investment objective by investingprimarily in equity securities of U.S. companies with small- and mid-market capitalizations (market value of publicly traded equitysecurities). The Advisor considers a company to be a “U.S. company” based on its domicile, its principal place ofbusiness, its primary stock exchange listing, and/or at least 50% of its revenues being derived from goods sold or produced, investmentsmade, or services performed in the U.S. The types of equity securities in which the Fund invests are common and preferred stocks,American Depositary Receipts (“ADRs”), and warrants and rights. Under normal market conditions, the Fund will investat least 80% of its net assets (plus any borrowings for investment purposes), measured at the time of purchase, in securitiesof U.S. companies with small- and mid-market capitalizations. Small and mid-capitalization companies are defined as issuers withmarket capitalizations based on total outstanding shares in the range of those included in the Russell 2500 Index measured atits most recent reconstitution date. As of July 1, 2025, the most recent reconstitution date of the index as of the date of thisprospectus, the market capitalization range of the Index was $60,545,972 to $23,940,608,000. This market capitalization rangemay change over time. The Fund may invest in securities of companies located outside of the United States, including emergingand frontier markets. The Fund may invest up to 5% of its total assets, measured at the time of purchase, in any one company.From time to time, the Fund may invest more than 20% of its assets in any market sector, such as the health care sector. TheFund may invest from time to time in cash or short-term cash equivalent securities as part of its overall investment strategy.The amount of such holdings will vary and will depend on the Advisor’s assessment of the quantity and quality of investmentopportunities that exist at any given time, and may at times constitute a material part of the Fund’s portfolio. BrandesInvestment Partners, L.P., the investment advisor (the “Advisor”), uses the principles of value investing to analyzeand select securities for the Fund’s investment portfolio. When buying securities, the Advisor assesses the estimated “intrinsic”value of a company based on data such as a company’s earnings, cash flow generation, and/or asset value of the underlyingbusiness. By choosing securities that are selling at a discount to the Advisor’s estimates of the underlying company’sintrinsic value, the Advisor seeks to establish an opportunity for long-term capital appreciation. The Advisor may sell a securitywhen its price reaches the Advisor’s estimate of the underlying company’s intrinsic value, or when the Advisor believesthat other investments are more attractive.

BSMC News

Data for BSMC is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.